Ampio is Preparing an Expanded Access FDA protocol to Study Nebulized Ampion as a Treatment for Moderate to Severe Acute Respiratory Distress Syndrome Associated with COVID-19

Stock Information for Zion Oil

Loading

Please wait while we load your information from QuoteMedia.